找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Congenital Bleeding Disorders; Diagnosis and Manage Akbar Dorgalaleh Book 20181st edition Springer International Publishing AG, part of Spr

[復制鏈接]
樓主: 召喚
41#
發(fā)表于 2025-3-28 17:02:33 | 只看該作者
Bernard-Soulier Syndromemore specific laboratory studies such as aggregometry assays, flow cytometry, and molecular analysis can help to precise and timely diagnosis of disorder. BSS treatment includes supportive cares as well as specific treatment of bleeding episodes.
42#
發(fā)表于 2025-3-28 19:17:38 | 只看該作者
43#
發(fā)表于 2025-3-29 01:34:13 | 只看該作者
44#
發(fā)表于 2025-3-29 04:24:55 | 只看該作者
Hemophilia Bcurring in ~1% of patients remains as a challenge of replacement therapy that can cause infused FIX concentrate to be less efficient. Gene therapy is the only definitive curative option, but some time will pass before it becomes available as a routine treatment choice.
45#
發(fā)表于 2025-3-29 07:42:31 | 只看該作者
Book 20181st editionces for disease-related morbidity and mortality. The authors are acknowledged specialists in the field from across the world who have particular expertise in the disorder that they discuss. The book will be of value to hematologists, oncologists, pediatricians, laboratory specialists and technicians, general physicians, and trainees.?.
46#
發(fā)表于 2025-3-29 11:28:45 | 只看該作者
enges that they pose.Provides up-to-date guidance on use of This book describes in detail the clinical presentation, diagnosis, and management of a wide range of congenital bleeding disorders. It will assist readers in overcoming the significant challenges involved in clinical and laboratory diagnos
47#
發(fā)表于 2025-3-29 18:31:24 | 只看該作者
Daniela Meneses Sala,Corina Rueda-Borrerothe more frequent cross-reactive material negative (CRM?) and the rare cross-reactive material positive (CRM+). Different therapeutic choices are available including fresh frozen plasma (FFP) and FXI concentrates that can provoke inhibitor formation, while recombinant FVII can be used for such patients.
48#
發(fā)表于 2025-3-29 21:38:28 | 只看該作者
Book 20181st editionaders in overcoming the significant challenges involved in clinical and laboratory diagnosis and in providing effective clinical care that makes optimal use of new products, including recombinant factor. .concentrate. The coverage ranges from hemophilia A and B and von Willebrand disease to rare ble
49#
發(fā)表于 2025-3-30 01:06:33 | 只看該作者
50#
發(fā)表于 2025-3-30 04:18:19 | 只看該作者
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2026-1-28 00:27
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
鸡泽县| 太康县| 门头沟区| 横山县| 黄冈市| 佛学| 黄冈市| 南城县| 灌云县| 章丘市| 察雅县| 罗田县| 马边| 邮箱| 凌源市| 垫江县| 花莲市| 丹江口市| 大石桥市| 花垣县| 五家渠市| 都昌县| 海南省| 太康县| 垫江县| 彭州市| 普安县| 铜川市| 洛浦县| 乌兰县| 连州市| 兴仁县| 宁强县| 海晏县| 巴楚县| 都兰县| 楚雄市| 咸阳市| 天峨县| 江陵县| 庆元县|